Table 3.

Mean outpatient drug and non-drug payments by payer over period among patients with schistosomiasis diagnoses who have praziquantel drug claims with non-capitated insurance plans, 2013–2018 (N = 88)

Payment by payer	2013–14 (n = 38)	2015–18 (n = 50)	P value*
Drug payment, US$, mean (95% CI)
Insurance	50 (33–67)	517 (413–621)	< 0.01
Patient out of pocket	60 (46–73)	94 (50–139)	0.07
Total	110 (93–126)	612 (510–713)	< 0.01
Non-drug payment, US$, mean (95% CI)
Insurance	534 (311–757)	475 (268–682)	0.35
Patient out of pocket	115 (47–184)	113 (57–170)	0.48
Total	649 (388–910)	588 (338–839)	0.37

^*P values are from one-tailed Welch’s t-test with unequal variances.